Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Fuji
Accenture
AstraZeneca
Harvard Business School
US Department of Justice
Farmers Insurance
Deloitte

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021835

« Back to Dashboard

NDA 021835 describes CLOBEX, which is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from four suppliers. There are six patents protecting this drug and three Paragraph IV challenges. Additional details are available on the CLOBEX profile page.

The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 021835
Tradename:CLOBEX
Applicant:Galderma Labs Lp
Ingredient:clobetasol propionate
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 021835
Medical Subject Heading (MeSH) Categories for 021835
Suppliers and Packaging for NDA: 021835
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBEX clobetasol propionate SPRAY;TOPICAL 021835 NDA Galderma Laboratories, L.P. 0299-3849 0299-3849-01 1 BOTTLE in 1 CARTON (0299-3849-01) > 10 mL in 1 BOTTLE
CLOBEX clobetasol propionate SPRAY;TOPICAL 021835 NDA Galderma Laboratories, L.P. 0299-3849 0299-3849-02 1 BOTTLE in 1 CARTON (0299-3849-02) > 59 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;TOPICALStrength0.05%
Approval Date:Oct 27, 2005TE:ATRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Feb 12, 2018Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 24, 2018Product Flag?YSubstance Flag?Delist Request?
Patented Use:TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.

Expired US Patents for NDA 021835

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs Lp CLOBEX clobetasol propionate SPRAY;TOPICAL 021835-001 Oct 27, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Galderma Labs Lp CLOBEX clobetasol propionate SPRAY;TOPICAL 021835-001 Oct 27, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Cantor Fitzgerald
US Army
Federal Trade Commission
Teva
Boehringer Ingelheim
Farmers Insurance
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.